Biohybrid system

A biohybrid system is a term used to refer to the integration of biological materials, such as cells or tissues, with artificial components, including electronics or mechanical structure. This combination leverages the inherent capabilities of living organisms alongside the precision of man-made technology, enabling the performance of tasks that neither biology nor machines could achieve independently.

For instance, biohybrid systems might utilize lab-cultured muscle cells to power small robots or combine sensors with living tissue for better health sensing. The intent behind these systems is basically to bring together the benefits of biological and technological components in order to introduce new solutions for complex medical challenges.

Biohybrid systems have transformative potential across multiple sectors such as robotics to create actuators and sensors that mimic natural muscle and nerve function, medicine in developing smart implants and drug delivery systems, in prosthetics for enhancing user control through neural or muscular interfaces and environmental sustainability for deploying biohybrid solutions for pollution sensing or remediation.

The term "biohybrid" is a compound of "bio" from biology (meaning life) and "hybrid" (referring to a combination of distinct elements), denoting a field of study. While hybrid bio-mechanical systems have been in development since the early 2000s, the term itself is relatively new.^{[original research?]} Its use helps distinguish such systems from purely biological constructs or entirely synthetic machines. Early academic mentions may include bio actuated robotics papers and foundational tissue-robot integration studies published in journals like Nature Biotechnology or Science Robotics. The emergence of the term reflects a growing recognition of the need to describe systems that do not fit cleanly into traditional categories.

One of the most significant biohybrid challenges is to engineer interfaces between living tissue and artificial materials that are efficient. This means having precise control over adhesion at the surface, diffusion of nutrients, and signal conduction. Actuation mechanisms within the heart of these systems generate movement or mechanical response. These may be in the form of living muscle cells such as skeletal myocytes or cardiomyocytes, soft pneumatic actuators, or electrical stimulation-responsive tissues.

Materials selection is equally critical. Hydrogels, elastomers like PDMS (polydimethylsiloxane), and biopolymers are commonly used due to their softness and biocompatibility. These materials must support cell viability, resist immune attack, and allow the integration of mechanical or electrical components.

At their core, biohybrid systems work by bridging living biological parts with technological aspects. Through this integration, functionality that neither system could accomplish singularly is made possible.

Biological parts may be cells, tissues, or even organs—occasionally cultured in a laboratory setting. These biological parts carry out biologically inspired behaviors, such as muscle contraction or chemical sensing in the body.

Technological Components constitute devices like sensors, electronic components, and structures that are mechanical. These constituents serve to manipulate the system, supply power, or transfer data. As a point of illustration, an example is a sensor that is implantable within a body and detects glucose levels as it sends information to a smart phone in real time.

By integrating these artificial and biological parts, biohybrid systems can perform advanced functions, such as tissue regeneration, real-time health monitoring, or the recovery of motor function in paralysis patients.

Biohybrid systems generally consist of two major components: the biological and the mechanical.

• Biological components include muscle cells for contraction, endothelial cells for vascularization, and stem cells for regenerative capabilities.
• Mechanical components comprise soft actuators that mimic organic motion, synthetic scaffolds that provide support and structure, and microfluidic systems that facilitate the delivery of nutrients and removal of waste.

These components are combined in a manner that allows for dynamic, lifelike behaviour—such as the contraction of tissue or the propagation of mechanical waves—while maintaining biocompatibility and durability.

The range of applications for biohybrid systems is broad and expanding. For robotics, biohybrid structures have been used to engineer microscopic, muscle-driven machines, such as Harvard's biohybrid stingray robot. In medical applications, they offer new alternatives for organ repair and augmentation, including biohybrid heart valves and esophageal scaffolds.

Biohybrids is also promising in neural interfaces, where the goal is to create long-lasting, stable interaction between mechanical devices and brain tissue. Muscle-actuated drug response platforms are under exploration in pharmacology for modelling and real-time screening.

Several high-profile research projects have demonstrated the potential of biohybrid systems:

• Harvard researchers developed a biohybrid swimming ray powered by rat cardiac cells layered onto a gold skeleton, mimicking the motion of a real stingray.
• At MIT, a cardiac pump actuated entirely by living heart muscle cells was engineered to simulate the behavior of a beating heart.
• Bio actuated soft robots have been built to simulate gut peristalsis, using muscle contractions to replicate natural wave-like movement in the digestive tract.

These examples showcase not only the feasibility but the versatility of biohybrid systems across disciplines.

As with many technologies that involve living systems, biohybrid systems raise important ethical and biomedical questions. Cell sourcing remains a key issue, particularly when embryonic or animal-derived cells are used. Long-term viability is another concern—living tissues must be kept alive with nutrients and oxygen, and they often degrade or elicit immune responses when implanted.

Powering these biological parts presents logistical and ethical hurdles as well. Systems must either include internal mechanisms for nutrient delivery or be supported externally, which can limit portability and independence.

Researchers are exploring self-directed, self-regulated organ substitutes and regenerative implants that can respond to their surroundings in real-time. These systems may be integrated with artificial intelligence to make them adjust to stimuli and coordinate complex behaviours, resulting in organoid intelligence.

Future potential applications are wearable biohybrid systems for rehabilitation, space medicine devices for long-duration missions, and implantable devices that fully integrate into human physiology.

Although biohybrid system overlaps with several established domains, it remains distinct in its emphasis on functional integration of biological and mechanical components. For example:

• Tissue engineering focuses primarily on the growth of biological tissues, often in static environments.
• Soft robotics employs flexible materials for motion, but typically lacks living components.
• Biomimicry includes biologically inspired robots but usually does not integrate real biological tissues.
• Organs-on-chips simulate organ functions using microfluidics, without actuation or muscular function.